article thumbnail

Daxxify, a New Anti-Wrinkle Drug and Botox Competitor is FDA-Approved

XTalks

Daxxify was FDA-approved for similar cosmetic purposes as Botox and other neuromodulators like Dysport and Xeomin. Many people choose to undergo non-invasive cosmetic procedures to prevent or reduce the appearance of signs of aging. A Novel Botox Competitor. ng of the core active ingredient.

Botox 98
article thumbnail

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

The Pharma Data

June 8, 2021 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1 , is connecting with consumers. “BOTOX ® Cosmetic is honoring and celebrating the dynamic people who use our products. IRVINE, Calif.

Botox 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aesthetic Alchemy: “Artistry of Medical Aesthetic Procedures”

Roots Analysis

It is interesting to note that medical aesthetics companies are continuously enhancing their product portfolio to provide solutions based on the needs of the end user. The medical aesthetics companies are offering advanced products and devices to perform these procedures with better results and minimal downtime.

Filler 40
article thumbnail

Medical Aesthetics: “Redefining Beauty through Medical Expertise”

Roots Analysis

Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. However, Botulinum toxin was the real game-changer when it was approved for cosmetic use by the FDA in 2002. What is Medical Aesthetics?

Filler 40
article thumbnail

Skin Tone Explored: Unraveling Complexities Through Research!

Trialfacts

radiotherapy) in the past 6 months Must not have performed any aesthetic treatment on the face within the past 12 months, including injections (fillers/ Botox/ permanent implants, etc.), No products will be used, unless instructed otherwise, at the study visit participants must: Remove all makeup the night before.

article thumbnail

AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results

The Pharma Data

– Full-Year Global Net Revenues from the Aesthetics Portfolio Were $2.590 Billion; Global Botox Cosmetic Net Revenues Were $1.112 Billion. Global Botox Cosmetic net revenues were $493 million , an increase of 9.1 Global Botox Therapeutic net revenues were $567 million , a decrease of 1.0

Botox 52
article thumbnail

AbbVie Reports Second-Quarter 2021 Financial Results

The Pharma Data

Global Botox Therapeutic net revenues were $603 million, an increase of over 100.0 Global Botox Cosmetic net revenues were $584 million, an increase of over 100.0 Refer to the Key Product Revenues schedules for further details. to $6.14; Raises 2021 Adjusted Diluted EPS Guidance Range from $12.37 Recent Events.

Botox 52